MarketResearch.com logo

Recent Multiple Sclerosis (MS) Research for November 2014


Relapsing Remitting Multiple Sclerosis (RRMS) - Pipeline Review, H2 2014
Topics: Multiple Sclerosis (MS), Drug Discovery
Relapsing Multiple Sclerosis (RMS) - Pipeline Review, H2 2014
Topics: Multiple Sclerosis (MS), Drug Discovery
KOL Insight: Multiple Sclerosis
Topics: Multiple Sclerosis (MS), Research & Development, Drug Discovery
Multiple Sclerosis - Pipeline Review, H2 2014
Topics: Multiple Sclerosis (MS), Drug Discovery
Global Multiple Sclerosis Drugs Market : 2014-2018
Topics: Multiple Sclerosis (MS), Research & Development, Drug Discovery
Regions: Global
Physician Views: How do neurologists value multiple sclerosis medical affairs teams – what could they be doing better?
Topics: Multiple Sclerosis (MS), Physicians' Offices
Relapsing Remitting Multiple Sclerosis (RRMS) Global Clinical Trials Review, H2, 2014
Topics: Multiple Sclerosis (MS), Clinical Trial
Regions: Global
Neurotech Industry 2014 Report
Topics: Alzheimer's Disease, Parkinson's Disease, Huntington's, Multiple Sclerosis (MS), Epilepsy, Neurology Devices, Research & Development, CNS/Neurology
Multiple Sclerosis Partnering 2009-2014
Topics: Multiple Sclerosis (MS), Pharmaceuticals Company Reports
Multiple Sclerosis Global Clinical Trials Review, H2, 2014
Topics: Multiple Sclerosis (MS), Clinical Trial
Regions: Global
Relapsing Multiple Sclerosis (RMS) Global Clinical Trials Review, H2, 2014
Topics: Multiple Sclerosis (MS), Clinical Trial
Regions: Global
Pharma-Patient Engagement: insights from patient opinion leaders
Topics: Multiple Sclerosis (MS), Physicians' Offices
EpiCast Report: Multiple Sclerosis - Epidemiology Forecast to 2023
Topics: Multiple Sclerosis (MS)
Regions: Global
Physician Views: What drives physician brand loyalty in the ultra-competitive multiple sclerosis market?
Topics: Multiple Sclerosis (MS), Physicians' Offices
Multiple Sclerosis (MS) Drugs and Biologics: Technologies and Global Markets
Topics: Biologics, Multiple Sclerosis (MS), Biopharmaceuticals
Regions: Global
Secondary Progressive Multiple Sclerosis (SPMS) - Pipeline Review, H2 2013
Topics: Multiple Sclerosis (MS), Drug Discovery
Multiple Sclerosis -- KOL Insight and Consensus Outlook Modules
Topics: Multiple Sclerosis (MS), Research & Development
Market Highlights: Italy Multiple Sclerosis – 2014
Topics: Multiple Sclerosis (MS), Drug Discovery
Regions: Italy
Update: Multiple Sclerosis Pipeline Highlights – 2014
Topics: Multiple Sclerosis (MS), Drug Discovery
Market Highlights: Spain Multiple Sclerosis – 2014
Topics: Multiple Sclerosis (MS)
Regions: Spain
Market Highlights: UK Multiple Sclerosis – 2014
Topics: Multiple Sclerosis (MS)
Regions: United Kingdom
Physician Views: Life-cycle management strategies in multiple sclerosis – can new versions of Copaxone, Avonex drive market share retention?
Topics: Multiple Sclerosis (MS), Physicians' Offices, Prescription Drugs
Regions: United States
Multiple Sclerosis: KOL Insight
Topics: Multiple Sclerosis (MS), Research & Development
Consensus Outlook: Multiple Sclerosis
Topics: Multiple Sclerosis (MS), Research & Development
Market Highlights: Germany Multiple Sclerosis – 2014
Topics: Multiple Sclerosis (MS)
Regions: Germany
Market Highlights: France Multiple Sclerosis – 2014
Topics: Multiple Sclerosis (MS)
Regions: France
Market Highlights: Japan Multiple Sclerosis – 2014
Topics: Multiple Sclerosis (MS)
Regions: Japan
Market Highlights: Europe Multiple Sclerosis – 2014
Topics: Multiple Sclerosis (MS)
Regions: Europe
Market Highlights: US Multiple Sclerosis – 2014
Topics: Multiple Sclerosis (MS)
Regions: United States
Global Multiple Sclerosis Market: Trends & Opportunities (2013-18)
Topics: Multiple Sclerosis (MS), Drug Discovery
Regions: Global
PharmaPoint: Multiple Sclerosis - Global Drug Forecast and Market Analysis to 2022 Event-Driven Update
Topics: Multiple Sclerosis (MS)
Regions: Global
Physician Views: As Tecfidera approaches a critical juncture in Europe, how are neurologist perceptions towards Biogen Idec's MS drug shaping up?
Topics: Multiple Sclerosis (MS)
Regions: Europe
Physician Views – Which multiple sclerosis players do the best marketing job? – FirstWord polls neurologists in the US and 5EU
Topics: Marketing, Multiple Sclerosis (MS), Physicians' Offices
Regions: United States
BIOGEN IDEC - Diversification and Strong Foothold in MS to Reign
Topics: Biotechnology Company Reports, Multiple Sclerosis (MS)
Biogen Idec – Poised to Grow Beyond MS
Topics: Biotechnology Company Reports, Multiple Sclerosis (MS)
Physician Views: Sanofi secures EU approval for its multiple sclerosis treatment Lemtrada – how will neurologists use it?
Topics: Multiple Sclerosis (MS), Physicians' Offices, CNS/Neurology
Physician Views: Will generic Copaxone have traction in the MS market given emergence of oral therapies?
Topics: Multiple Sclerosis (MS), Physicians' Offices, Generics Drugs
FirstImpact: FDA approval of Aubagio
Topics: Multiple Sclerosis (MS)


 

About MarketResearch.com
MarketResearch.com is an online aggregator selling over 400,000 market research reports, company profiles and country profiles from over 720 research firms. Our reports will provide you with the critical business and competitive intelligence you need for strategic planning and marketing research. Coverage includes the US, UK, Europe, Asia and global markets.